The Cigna Group (NYSE:CI – Get Free Report) issued its quarterly earnings data on Thursday. The health services provider reported $6.64 EPS for the quarter, missing analysts’ consensus estimates of $7.84 by ($1.20), RTT News reports. The Cigna Group had a return on equity of 18.42% and a net margin of 1.31%. During the same quarter in the prior year, the company posted $6.79 earnings per share. The Cigna Group updated its FY 2025 guidance to 29.500- EPS.
The Cigna Group Price Performance
Shares of The Cigna Group stock traded down $25.34 during trading on Thursday, reaching $277.97. The company’s stock had a trading volume of 2,740,727 shares, compared to its average volume of 1,632,412. The business has a 50 day moving average price of $296.05 and a 200-day moving average price of $324.99. The company has a market capitalization of $77.32 billion, a P/E ratio of 26.17, a price-to-earnings-growth ratio of 0.78 and a beta of 0.54. The company has a quick ratio of 0.72, a current ratio of 0.72 and a debt-to-equity ratio of 0.71. The Cigna Group has a 12-month low of $262.03 and a 12-month high of $370.83.
Wall Street Analysts Forecast Growth
CI has been the topic of several recent research reports. Truist Financial dropped their price objective on shares of The Cigna Group from $420.00 to $390.00 and set a “buy” rating on the stock in a report on Monday, January 6th. Barclays raised their price objective on shares of The Cigna Group from $405.00 to $420.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 5th. Royal Bank of Canada dropped their price target on shares of The Cigna Group from $384.00 to $377.00 and set an “outperform” rating on the stock in a research report on Friday, November 1st. StockNews.com downgraded shares of The Cigna Group from a “strong-buy” rating to a “buy” rating in a report on Monday, November 4th. Finally, Deutsche Bank Aktiengesellschaft decreased their price target on shares of The Cigna Group from $398.00 to $394.00 and set a “buy” rating on the stock in a research note on Monday, November 4th. One equities research analyst has rated the stock with a hold rating, fourteen have issued a buy rating and one has assigned a strong buy rating to the company. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and an average price target of $395.93.
About The Cigna Group
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.
Further Reading
- Five stocks we like better than The Cigna Group
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Is Tonix Pharmaceuticals the Next Biotech Breakout?
- Energy and Oil Stocks Explained
- DeepSeek Dip: Is the Nuclear Energy Sell-Off a Buying Opportunity
- What is a support level?
- ASML: Strengths and Upside Remain Despite DeepSeek Worries
Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.